Balloon for Use in Angioplasty with an Outer Layer of Nanofibers

• US 20070232996A1
• Filed: 04/28/2005
• Published: 10/04/2007
• Est. Priority Date: 04/29/2004
• Status: Abandoned Application

• Current Assignee: Millimed A/S
• Original Assignee: Cube Medical A/S
• Inventors: Andersen, Erik
• Application Number:
  US11/587,693
• Publication Number:
  US 20070232996A1
• Time in Patent Office: Days
• US Class Current: 604/103.20
• CPC Class Codes: A61F 2/958 Inflatable balloons for placing stents or stent-grafts
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61L 2300/114 Nitric oxide, i.e. NO
• CPC Class Codes: A61L 2300/604 Biodegradation
• CPC Class Codes: A61L 2400/12 Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61M 2025/1004 Balloons with folds, e.g. folded or multifolded
• CPC Class Codes: A61M 2025/1031 Surface processing of balloon members, e.g. coating or deposition; Mounting additional parts onto the balloon member's surface
• CPC Class Codes: A61M 2025/1075 having a balloon composed of several layers, e.g. by coating or embedding
• CPC Class Codes: A61M 25/1027 Making of balloon catheters
• CPC Class Codes: A61M 25/1038 Wrapping or folding devices for use with balloon catheters
• CPC Class Codes: A61M 25/104 used for angioplasty

Abstract

An expandable balloon for use in angioplasty procedures comprises a balloon having an outer surface layer, the outer surface layer being made from electrospun nanofibers and incorporating at least one pharmaceutically active substance, such as nitric oxide (NO). The outer surface layer may be formed on a separate flexible tubular member or sock, which is slipped over the balloon. A method of treating cell disorders in tubular structures of a living being comprises the steps of placing a coated balloon at a treatment site within the tubular structures, expanding the balloon at the treatment site, and releasing the pharmaceutically active substance at the treatment site. Optionally, a stent may be crimped onto the balloon prior to insertion of the balloon and scent into the tubular structures of the living being.

Claims

1. An expandable balloon for use in angioplasty procedures, comprising a balloon having an outer surface layer, the outer surface layer being made from nanofibers and incorporating at least one pharmaceutically active substance.

2. A balloon according to claim 1, further comprising an intermediate layer formed between the balloon and the outer surface layer, the intermediate layer being formed by dip-coating.

3. A balloon according to claim 1, wherein the outer surface layer is formed on a separate flexible tube and the outer surface layer is slipped over the balloon.

4. A balloon according to claim 3, wherein the flexible tube is folded, so that the flexible tube, when seen in cross-section, defines a spoke-and-hub-formation.

5. A balloon according to claim 1, wherein the pharmaceutically active substance comprises nitric oxide, and wherein the outer surface layer optionally further includes an acidic agent.

6. A balloon according to claim 1, wherein the outer surface layer is essentially made from a polymer matrix, which contains molecules capable of releasing the at least one pharmaceutically active substance.

7. A balloon according to claim 6, wherein the outer surface layer is essentially made from a polymeric linear poly(ethylenimine) diazeniumdiolate.

8. A balloon according to claim 1, wherein the pharmaceutically active substance is provided in the form of biodegradable beadings distributed between the nanofibers.

9. A balloon according to claim 1, wherein the outer surface layer is formed from spun nanofibers, such as electrospun nanofibers.

10. A kit comprising a stent and a coated balloon according to claim 1 for expanding the stent.

11. A kit according to claim 10, further comprising a guide wire for guiding the stent to a treatment site in tubular structures of a living being.

12. A kit according to claim 11, wherein the guide wire is provided with a coating.

24. Use of an acidic agent as catalyst for the release of nitric oxide in a balloon according to claim 1.

25. A method of treating cell disorders in tubular structures of a living being, comprising the steps of:

placing a balloon according to claim 1 at a treatment site within the tubular structures;

expanding the balloon at the treatment site.

releasing the pharmaceutically active substance at the treatment site.

26. A method according to claim 25, wherein the step of releasing is controlled by the presence of a ph-controlling substance contained in the outer surface layer.

27. A method according to claim 24, further comprising, prior to the step of placing the balloon, placing an unexpanded stent on the balloon;

and placing the stent at the treatment site along with the balloon; and

subsequently expanding the stent at the treatment site as the balloon is being expanded; and

subsequently deflating the balloon and removing it from the tubular structure while the stent is left at the treatment site.

13. A method of producing a balloon for use in angioplasty, the method comprising the step of forming an outer surface layer for the balloon by nanofibers, the outer surface layer containing at least one pharmaceutically active substance.

14. A method according to claim 13, wherein the outer surface layer is formed by spinning, such as by electrospinning.

15. A method according to claim 14, wherein the outer surface layer is applied in the unexpanded state of the balloon.

16. A method according to claim 13, further comprising, prior to the step of forming the outer surface layer, a step of dip-coating the balloon to form an intermediate layer.

17. A method according to claim 13, comprising:

forming the outer surface layer on a separate flexible tube;

slipping the flexible tube over the balloon.

18. A method according to claim 17, wherein the step of forming the outer surface layer on the flexible tube comprises:

providing at least one core member;

forming the flexible tube with the outer surface layer by electrospinning the nanofibers onto an outer surface of the core member.

19. A method according to claim 17 or 18, further comprising, subsequent to the step of slipping the flexible tube over the balloon, folding the flexible tube, so that the flexible tube, when seen in cross-section, defines a spoke-and-hub-formation.

20. A method according to claim 13, wherein the pharmaceutically active substance comprises nitric oxide.

21. A method according to claim 20, wherein the outer surface layer further comprises an acidic agent.

22. A method according to claim 13, wherein the outer surface layer is essentially made from a polymer matrix, which contains molecules capable of releasing the at least one pharmaceutically active substance.

23. A method according to claim 22, wherein the outer surface layer is essentially made from a polymeric linear poly(ethylenimine) diazeniumdiolate.